Ticker
CLSDCompany Name
CLEARSIDE BIOMEDICAL INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 32M | $ 3.52M | $ -1.5M | $ 0 | -6.3% |
3/31/2025 | $ 67.18M | $ 2.54M | $ -1M | $ 0 | -2.29% |
12/31/2024 | $ 79.46M | $ 16.44M | $ 0 | $ 0 | -20.69% |
9/30/2024 | $ 84.19M | $ 15.1M | $ -1M | $ 0 | -16.75% |
6/30/2024 | $ 79.98M | $ 15.4M | $ -1M | $ 0 | -18.01% |
3/31/2024 | $ 93.41M | $ 15.78M | $ -1.35M | $ 0 | -15.44% |
12/31/2023 | $ 122.54M | $ 1.76M | $ -1.35M | $ 0 | -0.34% |
9/30/2023 | $ 60.54M | $ 1.6M | $ -350K | $ 0 | -2.06% |
6/30/2023 | $ 65.75M | $ 1.33M | $ 30.29M | $ 0 | -48.09% |
3/31/2023 | $ 64.75M | $ 962K | $ 30.64M | $ 0 | -48.8% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for CLEARSIDE BIOMEDICAL INC is calculated as follows: (-1 * CF - Equity [ $ 8.69M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -9.35M ]) / Market Cap [ $ 73.98M ]
(=) Shareholder Yield [ 0.89% ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |